Vice President, Chemistry, Manufacturing and Controls

Dr. Kemmerer leads the chemistry, manufacturing, and controls (CMC) functions for HUYA’s in-licensed drug candidates. Dr. Kemmerer specializes in formulation and process development, scale-up and tech transfer, and manufacturing. He has accumulated more than 25 years of drug development experience in the pharmaceutical/biotech industry and has held roles of increasing levels of responsibility across various CMC functions at Merck and Pfizer. These included the development and manufacture of a broad range of drug products such as Emend®, Nexium® and Pepcid®. Dr. Kemmerer served as Director of Formulation at Avera, Inc., and VP of Pharmaceutical Development and Manufacturing at Neothetics, Inc., advancing central nervous system, irritable bowel syndrome and aesthetic fat reduction drug product candidates. Dr. Kemmerer received his PhD in Pharmaceutical Science at Temple University and BS in Chemistry from Pennsylvania State University.

Chris Kemmerer